The former Department of Industry, Tourism and Resources prepared a Fact Sheet [
PDF 119KB] that provides information on the aim and objective of providing the one-off A$10 million grant to support the establishment of a small-scale mammalian cell production facility in Australia.
It also provides some key findings from the independent Business Case study, which are:
- there is a niche market opportunity for Australia;
- $35 million of mammalian cell based clinical development work is sent to offshore Contract Manufacturing Organisations each year;
- an Australian facility could earn between $32 and $62 million per annum; and
- a facility would have positive net present values and reasonable internal rates of return of up to 34 per cent.
Please note: Applicants were advised to undertake their own analysis and not rely on indicative information provided by the Business Case study.
Please note: Applications closed 17 August 2007.
For further information please contact:
Pharmaceuticals Industry Strategy and Environment Section
Department of Innovation, Industry, Science and Research
GPO Box 9839
Canberra ACT 2601
AUSTRALIA
Tel: +61 2 6213 6398
Email: pharmaceutical@innovation.gov.au